
Advantages of Namzaric for Dementia
ARTICLE + VIDEO INFOMMERCIAL: Namazaric for dementia comes in a convenient, extended-release capsule. It conveniently combines today’s 2 most popular drugs for Alzheimer’s. Learn about easy-to-manage Namazaric.

ARTICLE + VIDEO INFOMMERCIAL: Namazaric for dementia comes in a convenient, extended-release capsule. It conveniently combines today’s 2 most popular drugs for Alzheimer’s. Learn about easy-to-manage Namazaric.

Nature provides some of the best therapies for Alzheimer’s. Daffodils specifically from Wales are a big source of Galanthamine for Alzheimer’s. Rosemary competes head-on with the Alzheimer’s drug donepezil. Learn more about these natural sources.

Eligible patients can now begin Leqembi treatment at home, potentially reducing repeated infusion-center visits while preserving essential medical supervision and safety monitoring.

MEDICATION: Razadyne (generic galantamine) is an FDA-Approved daffodil extract for Alzheimer’s. Learn how it significantly lowered mortality & eased cognitive decline.

MEDICATION VIDEO: Aricept® (generic DONEPEZIL) is the world’s most popular drug for Early-stage Alzheimer’s. Does it help in Advanced-stage Alzheimer’s?

COCHRANE SERIES, PART 3 – DEEP DIVE: False alarm. The Cochrane Review shook confidence in Leqembi. It rests on a scientific threshold its own source publicly disowned. Here’s why the evidence did not justify the alarm.

COCHRANE SERIES, PART 2 – HOW IT HAPPENED: A new review just went viral in the media, declaring Alzheimer’s drugs don’t work. Leading scientists say the methodology was fundamentally flawed.

COCHRANE SERIES, PART 1 – WHAT HAPPENED:
A respected review called a breakthrough Alzheimer’s drug useless. Experts shrugged. Investors, who normally panic on such news, barely noticed. Here’s why that matters — and what it means for families weighing their options.

CLINICAL INERTIA is when it’s much easier to start someone on a medication, and keep them on, than to take them off. Find out why most advanced dementia patients receive too many expensive, questionable medications.

In a new deal with Alloy Therapeutics, Biogen—the makers of Leqembi—is investing in RNA technology that could point toward what comes next in Alzheimer’s care.

UPLIFTING VIDEO: Peter Berry & his Alzheimer’s are cycling 350 miles to show it’s still possible to live well with dementia.

Researchers found that spending time with horses — equine therapy — eases Alzheimer’s symptoms. Find out why.

GENETICS & LIFESTYLE VIDEO: How do family history and genetics affect a healthy person’s risk of Alzheimer’s? Watch Harvard’s Top Alzheimer’s researcher, Dr. Rudy Tanzi, offer down-to-Earth insights.

Three important dementia studies focus on HS-AGING, a type of dementia almost as common as Alzheimer’s in the 85+ group. Yet few people have heard of it. Why? What makes it different?

An intriguing study of 120 grandmothers might surprise you. Doctors know socially engaged people have better cognition and less dementia. But can a person get too much of a good thing? What’s the right balance?

Enjoy this great duet between a musician with dementia and his son. A triumph of spirit over Alzheimer’s! Sing-a-long if you like!

It looks like a sneeze cannot give anyone Alzheimer’s. While Alzheimer’s abnormal disease proteins do spread from cell-to-cell, they are not “infectious”. Check out the facts.
No spam, only news and updates.



We use cookies and similar technologies to improve your experience, understand how our content is used, and support relevant advertising that helps keep Alzheimer’s Weekly free to readers. You can choose to accept, deny, or manage your preferences at any time. Declining certain cookies may affect features such as embedded videos, comments, and personalized advertising.